Nu-Med Plus (NUMD) Depreciation Expense (2012 - 2022)

Nu-Med Plus has disclosed Depreciation Expense across 11 years of filings, most recently posting $2015.0 for Q1 2022.

• Depreciation Expense for Q1 2022 came in at $2015.0, down 23.93% year-over-year; the trailing twelve-month figure through Mar 2022 was $8731.0 (down 23.38% YoY), and the FY2021 annual result was $9365.0, down 20.6% from the prior year.
• Depreciation Expense came in at $2015.0 for Q1 2022 at Nu-Med Plus, down from $2650.0 in the prior quarter.
• In the past five years, Depreciation Expense ranged from a high of $3803.0 in Q2 2018 to a low of $1417.0 in Q2 2021.
• The 5-year median for Depreciation Expense is $3048.0 (2020), against an average of $3016.6.
• Across the five-year window, Depreciation Expense surged 100.62% in 2018 and tumbled 53.51% in 2021, its largest moves.
• Nu-Med Plus' Depreciation Expense stood at $3774.0 in 2018, then retreated by 19.55% to $3036.0 in 2019, then decreased by 12.71% to $2650.0 in 2020, then changed by 0.0% to $2650.0 in 2021, then fell by 23.96% to $2015.0 in 2022.
• The last three Depreciation Expense figures came in at $2015.0 (Q1 2022), $2650.0 (Q4 2021), and $2649.0 (Q3 2021), per Business Quant data.